Acer Therapeutics Compliant with All Nasdaq Listing Criteria
NEWTON, Mass., Dec. 29, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
News
Osteal Therapeutics Announces Leadership Team Appointments
Four new executives from the life science industry each bring over twenty years of experience…
TransCode Therapeutics Announces FDA Authorization to Proceed with First-In-Human Clinical Trial
BOSTON, Dec. 29, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA Oncology…
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) — Procaps Group, S.A. (NASDAQ: PROC)…
Downtown Pediatrics P.C. Selects eClinicalWorks Cloud EHR
Wyoming pediatrics practice chooses eClinicalWorks to improve efficiency and productivity WESTBOROUGH, Mass.–(BUSINESS WIRE)–eClinicalWorks®, the largest…
Compulink Receives ONC Health IT Cures Update Certification to Support Compliance with the 21st Century Cures Act
NEWBURY PARK, Calif.–(BUSINESS WIRE)–#Certified—Compulink Healthcare Solutions, the leader in specialty specific all-in-one EHR solutions, has…
The Change Company Closes Sixth Investment Grade Securitization of 2022
Securitization was comprised entirely of mortgage loans originated by Change Lending, a Community Development Financial…
Cross River Bank Spreads Holiday Cheer and Warmth to Children in Need
Company’s compassion shines bright with continued commitment to giving back to the local community Employees…
Followill Elected Director of Enterprise’s General Partner
HOUSTON–(BUSINESS WIRE)–Enterprise Products Partners L.P. (“Enterprise” NYSE: EPD) today announced that Rebecca G. “Becca” Followill…
Clearmind Medicine Announces Shareholders Meeting Results
Tel Aviv, Israel / Vancouver, Canada, Dec. 29, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Check Point® Software Technologies Enhances Endpoint Security with Intel vPro Platform
Bolstering Check Point Harmony Endpoint with Intel® Threat Detection Technology enables customers to take advantage…
Junshi Biosciences Announces NEJM Publication of Results of Phase 3 Study of VV116 Versus PAXLOVID for Adults at High Risk for Progression to Severe COVID-19
SHANGHAI, China, Dec. 29, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
SinoHytec Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange, Offer Price Between HK$60 and HK$76 per H Share, Raise up to HK$1,540.7 million
HONG KONG, Dec 29, 2022 – (ACN Newswire) – The leading provider of fuel cell…
A Synergy of International Web3 Players, WIR Group & Sekuya, to Delve Deep into Possibilities for Impactful Web3 Mass Adoption
Jakarta, Indonesia–(Newsfile Corp. – December 28, 2022) – WIR Group, SE. Asia AR VR AI…
JCB partners with NPCI to offer 40% cashback for RuPay JCB Cardholders for in-store purchases in Thailand, Singapore and Bahrain
MUMBAI / TOKYO, Dec 29, 2022 – (JCN Newswire) – RuPay in partnership with JCB…
Cellectis secures a €40 million credit facility from the European Investment Bank to support its Research, Development and Innovation activities
The credit facility will enable Cellectis to support the development of its UCART product candidates…
Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference
MARLBOROUGH, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Micromem Update
Toronto, Ontario and New York, New York–(Newsfile Corp. – December 28, 2022) – Micromem Technologies…
ImmunoGen Announces Susan Altschuller on FMLA Leave; Interim CFO Appointed
WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates…
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)
BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms…